至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls

Nat Commun.. 2019; 
Jiang W1,2, Birtley JR3,4, Hung SC5,6, Wang W7, Chiou SH8, Macaubas C5,6, Kornum B9, Tian L10, Huang H8, Adler L5,11, Weaver G3, Lu L3, Ilstad-Minnihan A5, Somasundaram S5, Ayyangar S5, Davis MM6,8,12, Stern LJ3, Mellins ED13,14.
Products/Services Used Details Operation
Peptide Synthesis Non-biotinylated test peptides included 30 15-mer overlapping peptides derived from prepo-HCRT (Supplementary Data 1a, by Genscript) and the positive control peptide EBV486–500. Get A Quote

摘要

Individuals with narcolepsy suffer from abnormal sleep patterns due to loss of neurons that uniquely supply hypocretin (HCRT). Previous studies found associations of narcolepsy with the human leukocyte antigen (HLA)-DQ6 allele and T-cell receptor α (TRA) J24 gene segment and also suggested that in vitro-stimulated T cells can target HCRT. Here, we present evidence of in vivo expansion of DQ6-HCRT tetramer+/TRAJ24+/CD4+ T cells in DQ6+ individuals with and without narcolepsy. We identify related TRAJ24+ TCRαβ clonotypes encoded by identical α/β gene regions from two patients and two controls. TRAJ24-G allele+ clonotypes only expand in the two patients, whereas a TRAJ24-C allele+ clonotype expands in a cont... More

关键词